Application of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinically isolated syndromes

Multiple Sclerosis Journal

Volumn 18, Issue 1, 2012, Pages 39-44

  Gomez Moreno M ^a,b   Diaz Sanchez M ^a,c   Ramos Gonzalez A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

clinically isolated syndromes; diagnostic criteria; disseminated in space; disseminated in time; MRI; multiple sclerosis

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; COHORT ANALYSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PREDICTION; SPAIN; SYNDROME;

EID: 84855953038     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511417828     Document Type: Article

References (26)

1. Sadovnick AD, Ebers GC. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci. 1993 ; 20: 17-29 (Pubitemid 23056941)
2. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000 ; 343: 938-952
3. Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med. 2000 ; 343: 898-904
4. Comi G, Filippi M, Barkhof F, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis. Lancet. 2001 ; 357: 1576-1582 (Pubitemid 32488815)
5. Kappos L, Polman CH, Freedman MS, et al. Treatment with interferon beta-1b delays conversion to clinically definite MS in patients with clinically isolated syndromes. Neurology. 2006 ; 67: 1242-1249 (Pubitemid 44563835)
6. Comi G, Martinelli V, Rodegher M, et al. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet. 2009 ; 374: 1503-1511
7. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001 ; 50: 121-127
8. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald criteria''. Ann Neurol. 2005 ; 58: 840-846 (Pubitemid 41746873)
9. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research proposals. Ann Neurol. 1983 ; 13: 227-231 (Pubitemid 13158528)
10. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997 ; 120: 2059-2069 (Pubitemid 27493740)
11. Tintore M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol. 2000 ; 21: 702-706 (Pubitemid 30210434)
12. Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol. 2002 ; 52: 47-53 (Pubitemid 34693742)
13. Tintoré M, Rovira A, Rio J, et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology. 2003 ; 60: 27-30 (Pubitemid 36070639)
14. Korteweg T, Tintoré M, Uitdehaag B, et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol. 2006 ; 5: 221-227 (Pubitemid 43238345)
15. Swanton JK, Rovira A, Tintoré M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol. 2007 ; 6: 677-686 (Pubitemid 47064439)
16. Swanton JK, Fernando K, Dalton CM, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2006 ; 77: 830-833 (Pubitemid 44023177)
17. Díaz-Sánchez M, Mayra Gómez-Moreno M, Asunción Morales-Otal M, et al. Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes. Mult Scler. 2010 ; 16: 576-580
18. Rovira A, Swanton JK, Tintoré M, et al. A single, early MRI scan for diagnosing multiple sclerosis. Arch Neurol. 2009 ; 66: 587-592
19. Montalban X, Tintoré M, Swanton JK, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology. 2010 ; 74: 427-434
20. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. Ann Neurol. 2011 ; 69: 292-302
21. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
22. Frohman EM, Goodin DS, Calabresi PA, et al. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003 ; 61: 602-611 (Pubitemid 37082595)
23. Tintoré M, Rovira A, Brieva L, et al. Isolated demyelinating syndromes: comparison of CFS oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Mult Scler. 2001 ; 7: 359-363 (Pubitemid 33138345)
24. MRI predictors of early conversion to clinically definite MS in CHAMPS placebo group. Neurology. 2002 ; 59: 998-1005
25. Masjuan J, Álvarez-Cermeño JC, García-Barragán N, et al. Clinically isolated syndromes. A new oligoclonal band test accurately predicts conversion to MS. Neurology. 2006 ; 66: 576-578 (Pubitemid 43739891)
26. Villar ML, García-Barragán N, Sádaba MC, et al. Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis. J Neurol Sci. 2008 ; 266: 34-37 (Pubitemid 351186516)